Oppenheimer Initiates Coverage On Vaxart with Outperform Rating, Announces Price Target of $4
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer has initiated coverage on Vaxart (NASDAQ:VXRT) with an Outperform rating and set a price target of $4.
August 15, 2024 | 9:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer has initiated coverage on Vaxart with an Outperform rating and set a price target of $4.
The initiation of coverage with an Outperform rating and a specific price target of $4 by a reputable firm like Oppenheimer is likely to positively influence investor sentiment and drive short-term price appreciation for Vaxart.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100